Filana Therapeutics shares rose after the FDA lifted a clinical hold on simufilam, allowing an epilepsy study to proceed.
Compass Therapeutics shares fell after the FDA recommended a new trial before a marketing application for tovecimig.
Amgen said its experimental drug dazodalibep met the main goal in a late-stage Sjogren’s disease trial at 48 weeks.
Nutanix acquired Ryax Technologies to expand AI compute orchestration capabilities and integrate GPU optimization into its platforms.
Brent and WTI crude prices declined as Iran signaled possible Strait of Hormuz reopening and Saudi Arabia prepared to resume exports.
Endeavour Silver paused its primary ball mill at Guanacevi Mine after a mechanical issue and expects repairs within three ...
Celldex reported positive Phase 3 results for barzolvolimab in chronic spontaneous urticaria, meeting primary and secondary endpoints.
Vertex Pharmaceuticals reported Phase 2b AMPLIFIED results for inaxaplin in APOL1-mediated kidney disease patients.
Ionis Pharmaceuticals reported positive Phase 3 results for ulefnersen in FUS-ALS, showing significant improvement versus ...
Ligand agreed to acquire royalty and milestone rights for Santen’s Ryjunea eye drop for $23 million upfront, expanding its ...
MediWound received $3.3 million in U.S. government funding to support NexoBrid development for battlefield burn care and FDA IND preparation.
Cognex agreed to acquire RealSense for $500 million, expanding into 3D robotic perception and AI-powered machine vision technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results